Top

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedFeb 4

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of USP-grade bulk Metoprolol Tartrate API for formulation, with CoA and compliance with Buy American requirements.

Similar Contracts

Same NAICS industry code

Solicitation # SPE2DP-26-T-4361

The contract specifies the procurement of PAXLOVID, a combination antiviral medication containing nirmatrelvir and ritonavir, supplied in blister cards with each card containing two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet, representing a single daily dose. Each box contains ten blister cards, providing a full five-day treatment course with two doses per day. The product is manufactured by Pfizer Inc under part number NDC00069-5321-30 and is regulated by the FDA. The item has a fixed shelf life of 36 months, non-extendable, and must be packaged in compliance with DLA standards including MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must ensure protection from damage and use commercial-grade containers suitable for safe transport at the lowest carrier rate. Each shipment must be palletized per DLA requirements and marked with specific identifiers, and delivery is required FOB destination to the Navy Expeditionary Central Facility in Williamsburg, Virginia. The order quantity is 50 boxes, with a strict 20-day delivery window from the award date, and zero tolerance for quantity variance. Shipment must occur via the fastest traceable means, explicitly excluding parcel post, and must be delivered no later than April 28, 2026. Bidders must specify the manufacturer, part number, and source, and the contracting officer must refer the bid to a product specialist for FDA-regulated product confirmation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4360

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Therapeutic Dietary Supplement Manufacturing & FormulationThe contract seeks the manufacture of an unflavored, lactose-free therapeutic dietary supplement in powder form, with each packet containing 80 grams of product designed to be reconstituted into 8 to 10 ounces of liquid. The formulation must strictly comply with both FDA regulations and U.S. military nutritional standards, ensuring suitability for therapeutic use in controlled environments. Production must maintain consistent quality, stability, and safety profiles to meet the rigorous requirements of institutional and clinical applications under military oversight. The opportunity is issued as a subcontract under the NAICS code 325411 for Pharmaceutical and Biological Product Manufacturing, with a response deadline of August 5, 2026. Performance is required at Perry Point, Maryland, 21902, under the purview of the Department of Defense’s Medical Supply Chain PHFS. The solicitation is open to qualified manufacturers capable of scaling production reliably while adhering to all regulatory and nutritional specifications, with no set-aside provisions indicated. Bidders must ensure full alignment with the technical and compliance conditions outlined in the contract’s governing framework.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4342

The contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VERAPAMIL HYDROCHLORID

Solicitation # SPE2DP-26-T-4330

Verapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIETARY SUPPLEMENT, THE

Solicitation # SPE2DP-26-Q-0125

The contract specifies the procurement of an unflavored therapeutic dietary supplement in powder form, with each package containing six individual packets, each yielding 8 to 10 ounces of liquid when reconstituted. The product is lactose-free and must have a shelf life of 18 months, with no more than three months elapsed between manufacture and delivery to the government. Each package must be sealed in a unit container that protects the contents from damage and packed in commercial shipping containers suitable for safe transport at the lowest cost to the delivery point. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Palatalization must follow DLA Packaging Requirements for Procurement. The unit of issue is the package, with four packages required, delivered in two separate shipments to two distinct government addresses—one in Perry Point, Maryland, and another in San Antonio, Texas—by traceable freight means only, prohibiting parcel post. Delivery is required within 35 days after order date, with inspection and acceptance occurring at the destination. Pricing is firm fixed, with no variance allowed in quantity. The supplier must comply with federal clauses related to veteran employment reports, sustainable products, and wide area workflow payment. The item’s NSN is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4339

Sumatriptan Succinate Tablets, 100 mg in bottles of nine tablets, are procured for the acute treatment of migraine with or without aura in adults, with storage requirements between 20 to 25°C (68 to 77°F) and protection from light. The item is regulated by the FDA and must comply with strict shelf-life standards, requiring a non-extendable 24-month shelf life per RS016 and RS001 for Type I (Code M) items. Packaging and marking must adhere to MIL-STD-2073-1E, MIL-STD-129, and the latest Medical Marking Standard No. 1, while palletization follows DLA Packaging Requirements for Procurement. The contract specifies three line items totaling seven bottles, with delivery due within five days of order, FOB destination, and zero tolerance for quantity variance. Deliveries are directed to multiple U.S. military locations including APO AE 09094-3219 and JBER AK 99506, with shipping details and contact information provided for each. The solicitation number SPE2DP-26-T-4339 is issued by the Department of Defense, with procurement governed by the DLA Master List of Technical and Quality Requirements, and requires pre-award confirmation via EBS referral including manufacturer and NDC details. The required delivery dates span late July to late August 2026, with an established response deadline of August 3, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Surge-Capable Domestic BiomanufacturingThe contract seeks to establish large-scale domestic manufacturing of dermal substitutes in the United States with built-in surge capacity to support mass casualty and emergency response scenarios. The effort is focused on creating a resilient, onshore production capability capable of rapidly scaling output during public health emergencies, ensuring timely availability of critical wound care products when demand spikes. This initiative is aligned with national preparedness goals and underscores a strategic push to reduce reliance on overseas supply chains for life-saving medical materials. The award is structured as a subcontract under the Administration for Strategic Preparedness and Response within the Department of Health and Human Services, with a North American Industry Classification System code of 325411 for pharmaceutical and medicine manufacturing. The solicitation was posted on July 28, 2026, and responses are due by August 28, 2026. Although the place of performance is listed with a zip code of 77416, no specific city or state is provided, and no point of contact details are included. The contract does not specify a set-aside status, indicating it is open to all qualified entities regardless of size or ownership. The focus remains on achieving domestic production capacity that can maintain steady output and immediately ramp up during crises.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyNac Pharmaceuticals is seeking a subcontractor to supply Pioglitazone Active Pharmaceutical Ingredient (API) that meets USP-NF standards and complies with the Trade Agreements Act for use in the manufacturing of finished dosage forms. The opportunity is posted under NAICS code 325411, indicating classification within pharmaceutical preparation manufacturing, and the response deadline is August 13, 2026, at 7:30 PM Eastern Time. The API must adhere strictly to pharmacopeial specifications to ensure quality, safety, and compatibility with regulatory requirements for final product approval. The place of performance and point of contact details are not specified, suggesting the supplier’s location and logistics are flexible as long as deliverables meet contractual obligations. This procurement is part of a broader initiative by the Department of Veterans Affairs through its contractor Nac Pharmaceuticals, to secure a reliable supply chain for critical drug components in support of federal healthcare programs.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

W7702-266459 SYNTHESIS OF MOLECULES OF INTEREST

Solicitation # WS5762399690

All bids for the synthesis of molecules of interest must be submitted by August 4, 2026 at 2:00 PM EDT, with any submissions after this time deemed non-responsive, overriding any earlier deadlines listed on Ariba Discovery or CanadaBuys. The contract, titled W7702-266459, is issued by Defence Research and Development Canada – Suffield Research Centre for the production of organic, organophosphorus, pesticide-related, and pharmaceutical molecules, with a base term of one year and four optional one-year extensions available at the Crown’s discretion. The Government of Canada retains full ownership of all foreground intellectual property generated under this contract. The solicitation, numbered WS5762399690, was posted on July 28, 2026, and is managed by the Department of Public Works and Government Services with primary contact Matthew Havrilenko at matthew.havrilenko@tpsgc-pwgsc.gc.ca. Performance will occur in Alberta, and the NAICS code 325411 applies.

Department of Public Works and Government Services

POSTED

DEADLINE

TRANEXAMIC ACID INJECT

Solicitation # SPE2DP-26-T-4321

Tranexamic acid injection is a sterile, single-dose, unpreserved intravenous solution containing 10 mg of tranexamic acid USP per mL, formulated in 100 mL with 7 mg of sodium chloride USP in water for injection USP, with a pH range of 6.5 to 8.0. Each unit is supplied in a polymer bag sealed with a twist-off port and oversealed in an aluminum pouch, containing a total of 1000 mg of tranexamic acid. The product must be stored at 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F to 86°F), and has a non-extendable shelf life of 24 months. Each case contains ten single-dose bags, and the item is identified by NSN 6505-01-694-2815 and NDC 51754-0108-03, manufactured by EXELA PHARMA SCIENCES LLC. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must meet DLA packaging requirements for procurement, including palletization and protective measures to ensure safe transport. The contract specifies delivery to Fort Bragg, NC, within 20 days of award, with FOB destination terms, zero quantity variance, and inspection and acceptance occurring at the delivery point. The item is subject to defense information coverage requirements and must be shipped via traceable means, excluding parcel post. The solicitation number is SPE2DP-26-T-4321, with a response deadline of August 3, 2026, and the original required delivery date is July 29, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CALCIUM CARBONATE TABL

Solicitation # SPE2DP-26-T-4303

Calcium carbonate tablets, each containing 500 mg of active ingredient, are intended for the relief of heartburn, acid indigestion, sour stomach, and upset stomach. The product is peppermint-flavored, chewable, and supplied in a quantity of four bundles totaling 150 tablets per bundle. The item has a non-extendable shelf life of 36 months and must be stored at room temperature in a tightly closed container. Packaging and labeling must comply with DLA procurement standards, including MIL-STD-2073-1E for packaging and Medical Marking Standard No. 1, which supersedes MIL-STD-129. The product is subject to tailored higher-level quality requirements and is classified as a Type I (Code Q) item with strict compliance to technical and quality specifications outlined in the DLA Master List. Delivery is FOB destination, with a required delivery date of July 28, 2026, and a 20-day lead time. Shipment must be traceable, excluding parcel post, and addressed to Fort Bragg, North Carolina. The NSN is 6505-01-725-1756, and the contract solicitation number is SPE2DP-26-T-4303, issued by the Department of Defense under NAICS code 325411.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 5 days

View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 541611

New

Federal

Small Business Subcontracting Plan Development & ReportingThe contract requires the development, implementation, and ongoing reporting of a small business subcontracting plan that fully complies with Veterans Affairs guidelines, using the electronic Subcontracting Reporting System eSRS. The work must be performed in alignment with the NAICS code 541611, which pertains to management consulting services, and the plan must be designed to meet federal obligations for small business participation under VA procurement regulations. The contractor will be responsible for ensuring accurate data submission, proper classification of subcontractor types, and adherence to all VA-specific reporting standards throughout the duration of the project. The solicitation is issued under the Department of Veterans Affairs through Nac Pharmaceuticals and has a response deadline of August 13, 2026, with the opportunity posted on July 28, 2026. There is no specified set-aside type, and the place of performance and point of contact details are not provided. The contractor must be prepared to operate within the VA’s compliance framework, maintain transparent records of small business subcontracting efforts, and generate regular, auditable reports through eSRS to demonstrate progress and adherence to federal goals for small business inclusion. The successful bidder will need expertise in federal subcontracting compliance, experience with VA systems and reporting protocols, and a thorough understanding of eSRS workflows and deadlines.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Logistics and Distribution to PPV CentersThe contract pertains to the logistics and distribution of finished pharmaceuticals under FOB Destination terms to Department of Veterans Affairs and Department of Defense Prime Vendor distribution centers across the United States, ensuring timely and compliant delivery to federal healthcare supply nodes. It is structured as a subcontract with a NAICS code of 484220, indicating a focus on specialized freight logistics, and is issued by Nac Pharmaceuticals under the authority of the Department of Veterans Affairs. The solicitation is open for responses until August 13, 2026, with a firm deadline of 7:30 PM Eastern Time, requiring proposers to meet strict operational, regulatory, and supply chain standards to qualify for award, particularly around cold chain management, inventory accuracy, and federal delivery protocols. Delivery must align with federal procurement requirements, including traceability, security, and compliance with federal药品 regulations, and performance is expected nationwide without geographic restriction within the U.S.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Serialization and DSCSA Compliance ServicesNac Pharmaceuticals is seeking a subcontractor to provide comprehensive serialization and DSCSA compliance services, including full end-to-end implementation of GS1 Data Matrix encoding for product units, handling of EPCIS transaction data to ensure traceability across the pharmaceutical supply chain, and integration with the NABP directory for accurate verification and validation of product information. The work requires strict adherence to federal serialization regulations to support secure, interoperable tracking of pharmaceuticals from manufacturer to dispenser, with all data properly formatted and transmitted in compliance with DSCSA milestones. Subcontractors must demonstrate technical capability in GS1 standards, EPCIS messaging protocols, and NABP system integration to meet the operational demands of a major federal healthcare provider. The opportunity is posted under NAICS code 541330 and has a response deadline of August 13, 2026, with no set-aside classification specified. While the place of performance and point of contact are not detailed, the contract is tied to the Department of Veterans Affairs through Nac Pharmaceuticals as the prime contractor.

POSTED

DEADLINE

Pharmaceutical Packaging Materials SupplyNac Pharmaceuticals is seeking a subcontractor to supply high-density polyethylene (HDPE) bottles, child-resistant caps, and compliant labels for unit-of-use pharmaceutical packaging. The materials must meet stringent pharmaceutical standards to ensure safety, compliance, and functionality in a unit-dose format, with particular emphasis on child-resistant features and regulatory labeling requirements. The procurement is classified under NAICS code 326199, indicating it pertains to other plastic product manufacturing, and the anticipated contract award is intended to support the Department of Veterans Affairs' pharmaceutical distribution needs. Interested parties must submit responses by August 13, 2026, at 7:30 PM Eastern Time, with the solicitation posted on July 28, 2026. The performance location and detailed delivery specifications are not explicitly defined in the posting, but successful bidders will be expected to adhere to all applicable federal pharmaceutical packaging regulations and deliver materials that meet exact quality and certification benchmarks without deviation.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Tablet Manufacturing and PackagingNac Pharmaceuticals, acting on behalf of the Department of Veterans Affairs, is seeking a subcontractor to manufacture and package pioglitazone 15mg tablets in 30- and 90-tablet unit-of-use bottles under current Good Manufacturing Practices and the Drug Supply Chain Security Act requirements. The work must adhere to strict regulatory standards to ensure product safety, traceability, and compliance with federal pharmaceutical guidelines. The solicitation was posted on July 28, 2026, and responses are due by August 13, 2026, at 7:30 PM Eastern Time. The NAICS code 325412 identifies this as a pharmaceutical and medicinal product manufacturing opportunity. All manufacturing and packaging activities are expected to occur at the contractor’s facility, with no specified place of performance indicated. The contract is structured as a subcontract and is not subject to any set-aside provisions.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Pioglitazone Tablets

Solicitation # 36E79726R0030

The contract titled 6505--Pioglitazone Tablets is a solicitation issued by the Department of Veterans Affairs through Nac Pharmaceuticals with the solicitation number 36E79726R0030, posted on July 28, 2026, and with a response deadline of August 13, 2026, at 7:30 PM ET. The North American Industry Classification System code 325412 identifies this as a pharmaceutical manufacturing contract, specifying the procurement of pioglitazone tablets, a medication used primarily for diabetes management. The office responsible for this solicitation is located in Hines, Illinois, with a ZIP code of 60141, and the place of performance details are not specified. The primary point of contact is Teresa Hussain, Senior Contract Specialist, reachable via email at teresa.hussain@va.gov. There is no set-aside designation indicated for this opportunity, meaning it is open to all eligible vendors without restriction based on small business, veteran-owned, or other classifications. Interested parties must submit proposals through the SAM.gov portal before the deadline to be considered for award.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

NDC Registration and FDA Compliance Services

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Primary and Secondary Packaging of Prescription Medications

In-Vitro Diagnostic Substance Manufacturing

POSTED

DEADLINE

Manufacturing of Metoprolol Tartrate 25mg Tablets

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Small Business Subcontracting and Reporting ServicesThis contract involves providing specialized support services to the prime contractor aimed at enhancing their ability to meet small business utilization goals. The services include managing subcontract tracking to ensure accurate monitoring of subcontracts, facilitating compliance with Federal Acquisition Regulation (FAR) reporting requirements, and expediting payment processes to improve cash flow for subcontractors. The work under this subcontract is tailored to align with the specific needs of the prime contractor, ensuring adherence to mandated small business participation and regulatory standards. The contract is titled "Small Business Subcontracting and Reporting Services" and falls under NAICS code 541614, indicating a focus on business management consulting services. It is associated with the Department of Veterans Affairs, specifically through the agency Nac Pharmaceuticals (36E797). While detailed location and contact information are unspecified, the contract demonstrates a clear commitment to supporting governmental agencies in fulfilling small business involvement objectives within their procurement activities. This effort is crucial for maintaining transparency and accountability in subcontracting practices within federal acquisition frameworks.

Process, Physical Distribution, and Logistics Consulting Services

POSTED

6 months ago

DEADLINE

N/A

View Details